Vivian Wahrlich

Sep 19, 2024 | sciencedirect.com | Yujing Zhang |Xing LI |Jun-Xian Wang |Vivian Wahrlich

Postmenopausal osteoporosis (PMO) is becoming a major global health concern as the proportion of menopausal women increases due to the enhanced longevity of the population. In the U.S., PMO affects one in four women aged 65 years or older [1]. PMO is a debilitating and progressive metabolic bone disorder associated with multiple morbidities and a heightened risk of fracture [2].